The More Things Change, The More They Stay The Same: Healthcare Prosecutions In A Virtual World

The COVID-19 pandemic has changed the world in fundamental ways. One of the biggest changes is the increased access to, and reliance upon, telemedicine. The scope of that increase is astounding. In 2020, the number of Medicare visits conducted through telehealth increased 63-fold. From 2016 to 2022, the percentage of physicians using virtual visits grew from 14% to 80%. “What we saw during COVID was a real shift from the in-person visit to the phone visit […]

By | March 18th, 2023 ||

DEA Proposes New Telehealth Prescribing Rules

The COVID-19 public health emergency (PHE) is set to expire on May 11, 2023, and there seems to be a scramble to extend some of the pandemic-related flexibilities involving telehealth. On March 1, 2023, the Drug Enforcement Administration (DEA) released two notices of proposed rulemaking to allow some of those flexibilities to continue, but are nevertheless more restrictive than what has been permitted since the PHE went into effect. One proposed rule will no longer permit telehealth […]

By | March 15th, 2023 ||

Holland & Knight Health Dose: March 7, 2023

Holland & Knight Health Doseis an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week’s topics include:

Congress This Week: President to Release FY 2024 Budget Request
Healthcare Workforce RFI: Responses Due March 20, 2023
Ways and Means Republicans Release Oversight Priorities
Senate Advances ASPE Health Nominee
Bipartisan Pushback on the DEA’s Newly Proposed Rule on Telehealth Policies
House Oversight Launches […]

By | March 12th, 2023 ||